Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 27, 2015
Oral human papillomavirus is common in individuals with Fanconi anemiaSharon L Sauter, Susanne I Wells, Xue Zhang, et al.
Blood|February 10, 2017
Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional studyParinda A Mehta, Stella M Davies, Thomas Leemhuis, et al.
Transplantation|April 2, 2021
Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young AdultsYunZu Michele Wang, Ashley Teusink-Cross, Yasser Elborai, et al.
Cancers|April 3, 2021
Human Papillomavirus Oral- and Sero- Positivity in Fanconi AnemiaSharon L Sauter, Xue Zhang, Lindsey Romick-Rosendale, et al.
Blood|August 13, 2017
Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patientsPaula Río, Susana Navarro, Guillermo Guenechea, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2013
An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosisRebecca A Marsh, Mi-Ok Kim, Chunyan Liu, et al.
Bone Marrow Transplantation|September 29, 2023
T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AMLAlexandra M Satty, Elizabeth Klein, Audrey Mauguen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2017
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell TransplantationAndrew C Dietz, Parinda A Mehta, Adrianna Vlachos, et al.
Bone Marrow Transplantation|April 11, 2020
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II studyPooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2016
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell TransplantationPooja Khandelwal, Chie Emoto, Tsuyoshi Fukuda, et al.
Pageof 9